340 related articles for article (PubMed ID: 16325877)
1. The vervet monkey (Chlorocebus aethiops) as an experimental model for Trypanosoma brucei gambiense human African trypanosomiasis: a clinical, biological and pathological study.
Ouwe-Missi-Oukem-Boyer O; Mezui-Me-Ndong J; Boda C; Lamine I; Labrousse F; Bisser S; Bouteille B
Trans R Soc Trop Med Hyg; 2006 May; 100(5):427-36. PubMed ID: 16325877
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma brucei gambiense infection in vervet monkeys: a potential model for early-stage disease.
Gachie BM; Kagira JM; Karanja SM; Waema MW; Ngotho JM; Maina NW
J Med Primatol; 2014 Apr; 43(2):72-7. PubMed ID: 24494926
[TBL] [Abstract][Full Text] [Related]
3. Influence of trypanocidal therapy on the haematology of vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
Ngotho M; Kagira JM; Kariuki C; Maina N; Thuita JK; Mwangangi DM; Farah IO; Hau J
Acta Trop; 2011 Jul; 119(1):14-8. PubMed ID: 21420376
[TBL] [Abstract][Full Text] [Related]
4. IL-10 is up regulated in early and transitional stages in vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
Ngotho M; Maina N; Kagira J; Royo F; Farah IO; Hau J
Parasitol Int; 2006 Dec; 55(4):243-8. PubMed ID: 16901747
[TBL] [Abstract][Full Text] [Related]
5. [Human African trypanosomiasis, contributions of experimental models].
Bouteille B; Millet P; Enanga B; Mezui Me J; Keita M; Jauberteau MO; Georges A; Dumas M
Bull Soc Pathol Exot; 1998; 91(2):127-32. PubMed ID: 9642464
[TBL] [Abstract][Full Text] [Related]
6. Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis.
Amin DN; Rottenberg ME; Thomsen AR; Mumba D; Fenger C; Kristensson K; Büscher P; Finsen B; Masocha W
J Infect Dis; 2009 Nov; 200(10):1556-65. PubMed ID: 19827943
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma brucei brucei: a long-term model of human African trypanosomiasis in mice, meningo-encephalitis, astrocytosis, and neurological disorders.
Keita M; Bouteille B; Enanga B; Vallat JM; Dumas M
Exp Parasitol; 1997 Feb; 85(2):183-92. PubMed ID: 9030668
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Grammomys surdaster thicket rats to Trypanosoma brucei gambiense infection.
Büscher P; Bin Shamamba SK; Ngoyi DM; Pyana P; Baelmans R; Magnus E; Van Overmeir C
Trop Med Int Health; 2005 Sep; 10(9):850-5. PubMed ID: 16135191
[TBL] [Abstract][Full Text] [Related]
9. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S; Efferth T
Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
[TBL] [Abstract][Full Text] [Related]
10. Use of procyclic trypanosomes for detection of antibodies in sera from vervet monkeys infected with Trypanosoma rhodesiense: an immunodiagnostic test for African sleeping sickness.
Pearson TW; Liu M; Gardiner IC; Longridge D; Beecroft RP; Sayer PD; Gould SS; Waitumbi JN; Njogu AR
Acta Trop; 1986 Dec; 43(4):391-9. PubMed ID: 2882666
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma brucei rhodesiense transmitted by a single tsetse fly bite in vervet monkeys as a model of human African trypanosomiasis.
Thuita JK; Kagira JM; Mwangangi D; Matovu E; Turner CM; Masiga D
PLoS Negl Trop Dis; 2008; 2(5):e238. PubMed ID: 18846231
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa.
Truc P; Lejon V; Magnus E; Jamonneau V; Nangouma A; Verloo D; Penchenier L; Büscher P
Bull World Health Organ; 2002; 80(11):882-6. PubMed ID: 12481210
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma brucei rhodesiense infection in vervet monkeys. I. Parasitologic, hematologic, immunologic and histologic results.
Schmidt H; Sayer P
Tropenmed Parasitol; 1982 Dec; 33(4):249-54. PubMed ID: 7164166
[TBL] [Abstract][Full Text] [Related]
14. Immunospecific immunoglobulins and IL-10 as markers for Trypanosoma brucei rhodesiense late stage disease in experimentally infected vervet monkeys.
Ngotho M; Kagira JM; Jensen HE; Karanja SM; Farah IO; Hau J
Trop Med Int Health; 2009 Jul; 14(7):736-47. PubMed ID: 19573160
[TBL] [Abstract][Full Text] [Related]
15. Loop Mediated Isothermal Amplification for Detection of Trypanosoma brucei gambiense in Urine and Saliva Samples in Nonhuman Primate Model.
Ngotho M; Kagira JM; Gachie BM; Karanja SM; Waema MW; Maranga DN; Maina NW
Biomed Res Int; 2015; 2015():867846. PubMed ID: 26504841
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide production in vervet monkeys (Cercopithecus aethiops) infected with Trypanosoma brucei.
Sternberg JM; Njogu Maina N; Gickhuki CW; Ndung'U JM
Parasite Immunol; 1998 Aug; 20(8):395-7. PubMed ID: 9767605
[TBL] [Abstract][Full Text] [Related]
17. IgM, lgG and IL-6 profiles in the Trypanosoma brucei brucei monkey model of human African trypanosomiasis.
Waema MW; Maina NW; Ngotho M; Karanja SM; Gachie BM; Maranga DN; Kagira JM
Acta Trop; 2017 Apr; 168():45-49. PubMed ID: 28099874
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and neuropathogenesis issues in human African trypanosomiasis.
Kennedy PG
Int J Parasitol; 2006 May; 36(5):505-12. PubMed ID: 16546191
[TBL] [Abstract][Full Text] [Related]
19. Serodiagnosis of African sleeping sickness in vervet monkeys by detection of parasite antigens.
Liu MK; Pearson TW; Sayer PD; Gould SS; Waitumbi JN; Njogu AR
Acta Trop; 1988 Dec; 45(4):321-30. PubMed ID: 2907259
[TBL] [Abstract][Full Text] [Related]
20. Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African Trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in southern Sudan.
Chappuis F; Stivanello E; Adams K; Kidane S; Pittet A; Bovier PA
Am J Trop Med Hyg; 2004 Sep; 71(3):313-7. PubMed ID: 15381812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
